Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Cancelled Post Market

Current status date:

2021-06-02

Original market date: See footnote 1

2004-12-29

Lot number: See footnote 2

804571

Expiry date: See footnote 2

2021-10-31

Product name:

NORPROLAC

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02223740

Product Monograph/Veterinary Labelling:

Date: 2013-10-29 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

FERRING INC
500 200 Yorkland Blvd
Toronto
Ontario
Canada M2J 5C1

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

92:00.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

G02CB04 QUINAGOLIDE

Active ingredient group (AIG) number:See footnote5

0150023001

List of active ingredient(s)
Active ingredient(s) Strength
QUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE) 0.025 MG
Version 4.0.2
Date modified: